All In Biotech

Drug Trial Radar · NCT07116746

Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients

A Phase 2, Multicenter, Open-label, Efficacy and Safety Study of AR882 and XOI Co-administration in Participants With Uncontrolled Gout Who Have Previously Failed Uricase Treatment

Last checked: Nov 19, 2026Latest source record: May 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

15

Planned (sponsor's estimate)

Start

Dec 3, 2025

Primary completion

Nov 2026

Study completion Feb 2027

Sponsor

Lead sponsor
Arthrosi TherapeuticsIndustry
Sponsor type
Industry
First posted
Aug 12, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 85 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will assess the effect of AR882 and XOI co-administration on sUA lowering as well as reducing tophus burden in the population that has failed uricase treatment (eg., pegloticase). Failed uricase treatment is defined as having an inherent intolerance, anaphylaxis, infusion reaction, antibody development, and/or at least one sUA level that rose to greater than 6 mg/dL while on therapy.

Conditions

  • Gout
  • Gouty Arthritis
  • Hyperuricemia
  • Gout Chronic
  • Refractory Gout
  • Uncontrolled Gout
  • Tophaceous Gout

Interventions

  • AR882 75 mgDrug

    Solid Oral Capsule

  • XOI Low DoseDrug

    Solid Oral Tablet

  • XOI High DoseDrug

    Solid Oral Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Serum urate (uric acid) (sUA) level < 6 mg/dL at month 6Time frame: 24 weeks

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Arthrosi Investigative Site (105)

    Margate, Florida

  • Arthrosi Investigative Site (102)

    Miami, Florida

  • Arthrosi Investigative Site (109)

    Tampa, Florida

  • Arthrosi Investigative Site (106)

    Jackson, Mississippi

  • Arthrosi Investigative Site (108)

    Charlotte, North Carolina

  • Arthrosi Investigative Site (103)

    Duncansville, Pennsylvania

  • Arthrosi Investigative Site (104)

    West Lake Hills, Texas

  • Arthrosi Investigative Site (107)

    Bellevue, Washington

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.